Skip to main content
Caplight Logo









Karavela

Karavela

Private
ParisHealthcare & Life Scienceshttps://karavela.ai/en

Last Round

Pre Seed

Aug 22, 2025

Total Funding Raised

$2.32M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Karavela is a healthcare and digital health company that develops brain foundation models using magnetic resonance imaging data to enhance clinical trials and neurological diagnostics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Imaging, Drug Discovery, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Foundation

Keywords

foundation modelbrain foundation modelfMRIfunctional magnetic resonance imagingneurological drug developmentclinical trial optimizationpatient stratificationbiomarker identificationbrain decodingfrontier AI labmedical AIneurotechdeep learningtransformer modelsclinical research organizationCRObiotech AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Karavela Comparables

Compare Karavela with similar companies based on industry and business-model similarity.

Karavela comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ceretype Neuromedicine, Inc.
83%
Qynapse
69%
IXICO plc
67%

Karavela Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedAug 22, 2025

Key People

Founding team and executive leadership

Alexis Thual

Cofounder & CEO

Founding Team

Karavela Investors

Notable investors and investment history

Karavela investors
InvestorRounds
DaphniPre Seed
First Momentum VenturesPre Seed
HCVCPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 27, 2026

    Grew 50% QoQ, from 6 to 9 employees.

  • Apr 12, 2026

    Grew 80% QoQ from 5 to 9 employees.

Karavela Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Karavela Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Karavela's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Employee Range10
Year Founded2025
Last FundingAug 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?